Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1632 studies found for:    Open Studies | "Genetic Diseases, Inborn"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Genetic Diseases, Inborn"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Mutations in Genes Associated With Pentalogy of Cantrell
Conditions: Inborn Genetic Diseases;   Pentalogy of Cantrell
Intervention:
2 Recruiting Pilot Study of Cardiac MR in Patients With Muscular Dystrophy
Conditions: Muscular Dystrophies;   Cardiac Fibrosis;   Genetic Diseases, Inborn;   Musculoskeletal Diseases
Intervention:
3 Recruiting Non Invasive Prenatal Testing (NIPT) of Single-gene Disorders
Condition: Hereditary Disease
Intervention:
4 Recruiting Biomarker for Hypophosphatasia Disease
Conditions: HEREDITARY DISEASES;   METABOLISM, INBORN ERRORS;   Hypophosphatasia
Intervention:
5 Recruiting Genomic Sequencing for Childhood Risk and Newborn Illness
Conditions: Hereditary Disease;   Genetic Predisposition to Disease
Interventions: Genetic: Genomic sequencing;   Other: Family history report
6 Recruiting North Carolina Newborn Exome Sequencing for Universal Screening
Conditions: Metabolism, Inborn Errors;   Hearing Loss;   Hereditary Disease
Interventions: Genetic: Well infant, whole exome sequencing;   Genetic: Diagnosed, whole exome sequencing
7 Recruiting Biomarker for Patients With a Cystic Fibrosis Disease
Conditions: Cystic Fibrosis;   Mucoviscidosis;   Hereditary Disease
Intervention:
8 Recruiting A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists
Conditions: Eczema;   Dermatitis;   Dermatitis, Atopic;   Genetic Disease, Inborn;   Hypersensitivity;   Hypersensitivity, Immediate;   Immune System Diseases;   Skin Diseases;   Skin Diseases, Eczematous;   Skin Diseases, Genetic
Interventions: Other: Care provided by general pediatrician;   Other: Care provided by pediatric dermatologist
9 Recruiting Drug & Gene Interaction Risk Analysis With & Without Genetic Testing Among Patients Undergoing MTM
Conditions: Cytochrome P450 CYP2D6 Enzyme Deficiency;   Poor Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Ultrarapid Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Extensive Metabolizer Due to Cytochrome P450 CYP2D6 Variant;   Cytochrome P450 CYP2C9 Enzyme Deficiency;   Cytochrome P450 CYP2C19 Enzyme Deficiency;   Drug Metabolism, Poor, CYP2D6-RELATED;   Drug Metabolism, Poor, CYP2C19-RELATED;   CYP2D6 Polymorphism
Interventions: Genetic: Pharmacogenetic testing;   Other: Software-based drug & gene interaction risk analysis;   Other: MTM
10 Recruiting Diagnosis and Treatment of Patients With Inborn Errors of Metabolism
Condition: Metabolism
Intervention:
11 Available Expanded Access to T-cell Depleted Haplo-Identical Stem Cells for Patients Receiving Haplo-Identical and Unrelated Cord Blood Transplants
Conditions: Hematologic Malignancies;   Inborn Errors of Metabolism Disorders;   Immune Deficiencies
Intervention: Biological: CliniMACS CD34 Reagent System
12 Recruiting The NIH MINI Study: Metabolism, Infection, and Immunity in Inborn Errors of Metabolism
Conditions: UCD;   MMA;   Acidemias;   Fatty Acid Oxidation Defects;   Mitochondrial Disease
Intervention:
13 Recruiting Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Conditions: Hematologic Disorders;   Hemoglobinopathies;   Immunodeficiencies
Interventions: Drug: Busulfan;   Drug: Fludarabine;   Radiation: Total body irradiation;   Biological: Stem cell transplant;   Drug: Keppra
14 Recruiting Biomarker for Patients With Transthyretin-Related Familial Amyloidotic Polyneuropathy
Conditions: Metabolic Diseases;   Amyloid Neuropathies;   Amyloidosis, Familial;   Polyneuropathies
Intervention:
15 Recruiting Biomarker for Mucolipidosis Disorder Type I, II, III or IV
Conditions: Mucolipidosis Type I;   Mucolipidosis Type II;   Mucolipidosis Type III;   Mucolipidosis Type IV;   Mucolipidosis
Intervention:
16 Not yet recruiting Anti-oxLDL IgM Antibodies as a Novel Therapy for Metabolic Lipid Diseases
Condition: Lipid Metabolism, Inborn Errors
Intervention: Biological: Anti-oxLDL IgM antibody
17 Recruiting Biomarker for Patients With Hurler Disease or High-grade Suspicion for Hurler Disease
Conditions: Mucopolysaccharidosis Type I;   MPS I;   Hurler-Scheie Syndrome;   Gargoylism, Hurler Syndrome
Intervention:
18 Recruiting A Clinical Trial for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency Using AAV2-hAADC - An Expansion
Condition: Aromatic Amino Acid Decarboxylase Deficiency
Intervention: Drug: AAV2-hAADC
19 Recruiting A Single-Stage, Adaptive, Open-label, Dose Escalation Safety and Efficacy Study of AADC Deficiency in Pediatric Patients
Condition: AADC Deficiency
Intervention: Drug: AAV2-hAADC
20 Not yet recruiting Review of French Cases of Glutathione Synthetase Deficiency
Condition: The Glutathione Synthetase Deficiency
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.